Table Of Contents:
1. Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
2. How to Qualify Container Closure Systems for Intended Use, Part 1
3. Are You Part of the Solution or Part of the Problem?
4. Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2
5. Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
6. Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
7. Calculations
8. Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
9. Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
10. Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
11. Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
12. Sulfasalazine 100 mg/mL in SyrSpend SF pH4
13. Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
14. Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
15. Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
16. Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
17. Zonisamide 10 mg/mL in SyrSpend SF pH4
18. Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
19. Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
20. Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
21. Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt